Claritas Rx Named to the 2026 Inc. 5000 List for the Second Consecutive Year
Recognition Marks the Company’s Second Straight Year on the Prestigious List of America’s Fastest-Growing Private Companies — and Comes as Claritas Rx Celebrates 15 Years Partnering with Life Sciences Clients
Claritas Rx, the patient journey experts, announced today it has been named to the 2026 Inc. 5000 list for the second consecutive year, earning a place among America's fastest-growing private companies. The list is the most prestigious ranking of the nation’s most successful independent and entrepreneurial businesses, recognizing companies that have achieved remarkable growth while driving innovation, creating jobs, and shaping the future of the economy. Past honorees include companies such as Microsoft, Meta, Chobani, Oracle, and Patagonia.
The back-to-back honor comes as Claritas Rx marks 15 years in business, a milestone that underscores the company's long-standing role as a trusted partner to biopharma companies working to help patients start and stay on therapy.
"We are honored to be named to the Inc. 5000 for the second consecutive year," said Michael Fitzgibbons, CEO of Claritas Rx. "This year is especially meaningful, as it also marks 15 years of Claritas Rx being a trusted partner to our clients. That commitment is what has fueled our growth year after year. Making this list twice in a row is a reflection of the trust our clients place in us, and of a team that stays focused on our promise: progress for every patient journey."
